telavancin

In September 2009, the FDA approved a long-awaited new drug in another new class (lipoglycopeptides, partially modeled on vancomycin) called telavancin (Vibativ).

SUPERBUG MARYN MCKENNA 2010

In September 2009, the FDA approved a long-awaited new drug in another new class (lipoglycopeptides, partially modeled on vancomycin) called telavancin (Vibativ).

SUPERBUG MARYN MCKENNA 2010

In September 2009, the FDA approved a long-awaited new drug in another new class (lipoglycopeptides, partially modeled on vancomycin) called telavancin (Vibativ).

SUPERBUG MARYN MCKENNA 2010

The panel voted 21 to 5 to recommend approval of telavancin, which is also designed to treat MRSA infections that don't respond to currently used antibiotics.

FierceBiotech 2008

But telavancin was approved only for serious skin and “skin structure” infections, not for the most serious invasive syndromes such as osteomyelitis, bacteremia, or endocarditis.

SUPERBUG MARYN MCKENNA 2010

But telavancin was approved only for serious skin and “skin structure” infections, not for the most serious invasive syndromes such as osteomyelitis, bacteremia, or endocarditis.

SUPERBUG MARYN MCKENNA 2010

But telavancin was approved only for serious skin and “skin structure” infections, not for the most serious invasive syndromes such as osteomyelitis, bacteremia, or endocarditis.

SUPERBUG MARYN MCKENNA 2010

The FDA posted a review Monday of telavancin and oritavancin ahead of the meeting.

New Antibiotics Take Aim at Staph's Rise 2008

The agency also noted that 18 patients receiving telavancin or vancomycin died during studies and said some deaths in both groups were possibly drug-related.

New Antibiotics Take Aim at Staph's Rise 2008

However, the FDA said it was concerned about an "imbalance" in the number of serious adverse events that involved the kidneys, with more patients receiving Theravance's telavancin having some problems when compared with those receiving vancomycin.

New Antibiotics Take Aim at Staph's Rise 2008